UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lifelong aerobic exercise protects against inflammaging and cancer

PloS one, 2019-01, Vol.14 (1), p.e0210863-e0210863

2019

Volltextzugriff (PDF)

A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly

Nutrients, 2020-08, Vol.12 (8), p.2391

2020

Volltextzugriff (PDF)

Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework

European respiratory review, 2021-09, Vol.30 (161), p.210104

2021

Volltextzugriff (PDF)

Taking modern psychiatry into the metaverse: Integrating augmented, virtual, and mixed reality technologies into psychiatric care

Frontiers in digital health, 2023-03, Vol.5, p.1146806-1146806

2023

Volltextzugriff (PDF)

Correction: Lifelong aerobic exercise protects against inflammaging and cancer

PloS one, 2020-05, Vol.15 (5), p.e0233401-e0233401

2020

Volltextzugriff (PDF)

Immersive Virtual Reality for Surgical Training: A Systematic Review

The Journal of surgical research, 2021-12, Vol.268, p.40-58

2021

Volltextzugriff (PDF)

Immersive Virtual Reality for Patient-Specific Preoperative Planning: A Systematic Review

Surgical innovation, 2023-02, Vol.30 (1), p.109-122

2023

Volltextzugriff (PDF)

Assessment of 30 Years of Randomized Controlled Trials in The American Journal of Sports Medicine: 1990-2020

Orthopaedic Journal of Sports Medicine, 2023-05, Vol.11 (5), p.23259671231161293-23259671231161293

2023

Volltextzugriff (PDF)

A Systematic Review of using Virtual and Augmented Reality for the Diagnosis and Treatment of Psychotic Disorders

Current treatment options in psychiatry, 2023-06, Vol.10 (2), p.87-107

2023

Volltextzugriff (PDF)

Trauma 101: a virtual case-based trauma conference as an adjunct to medical education

Canadian Journal of Surgery, 2021-10, Vol.64, p.S56-S56

2021

Volltextzugriff (PDF)

Bile Duct Papillary Adenoma Degenerating Into Cholangiocarcinoma: 197

The American journal of gastroenterology, 2015-10, Vol.110, p.S86

2015

Volltextzugriff (PDF)

Validity and Reliability of a Rosacea Self-Assessment Tool

Dermatologic clinics, 2018-04, Vol.36 (2), p.93-96

2018

Volltextzugriff (PDF)

Rosacea Patient Perspectives on Homeopathic and Over-the-counter Therapies

The Journal of clinical and aesthetic dermatology, 2015-10, Vol.8 (10), p.30-34

2015

Volltextzugriff (PDF)

Abstract 2745: INK128, a TORC1/2 kinase inhibitor, enhances the efficacy of cytotoxic therapies in endometrial tumor models

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.2745-2745

2012

Volltextzugriff (PDF)

Abstract 3753: Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3753-3753

2012

Volltextzugriff (PDF)

Abstract A171: A potent and selective PI3K inhibitor, INK1117, targets human cancers harboring oncogenic PIK3CA mutations

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A171-A171

2011

Volltextzugriff (PDF)

Abstract A172: INK128, an orally active TORC1/2 kinase inhibitor, displays enhanced efficacy when combined with cytotoxic agents

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.A172-A172

2011

Volltextzugriff (PDF)

Abstract 4486: INK128, a novel TORC1/2 inhibitor with potent oral antitumor activity in preclinical models of renal cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4486-4486

2011

Volltextzugriff (PDF)

Abstract 4501: INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4501-4501

2011

Volltextzugriff (PDF)

Abstract 1668: Pharmacodynamic biomarker development for INK128, a potent and selective inhibitor of TORC1/2 for the treatment of cancer

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.1668-1668

2010

Volltextzugriff (PDF)

Abstract 4488: INK128: An orally active TORC1/2 kinase inhibitor demonstrates potent antitumor activity in preclinical models of renal cell carcinoma

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4488-4488

2010

Volltextzugriff (PDF)

Abstract 4496: INK128, an orally active TORC1/2 kinase inhibitor, shows broad antitumor activity and enhances efficacy of cytotoxic as well as targeted agents

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.4496-4496

2010

Volltextzugriff (PDF)

Abstract B148: INK128 is a potent and selective TORC1/2 inhibitor with broad oral antitumor activity

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B148-B148

2009

Volltextzugriff (PDF)

Chapter 2 - Proposed curriculum for an interventional psychiatry fellowship program

Interventional Psychiatry, 2024, p.17-28

2024

Volltextzugriff (PDF)

Book Review

Journal of Dermatological Treatment, 2015, Vol.26 (3), p.297-297

Lan, Lucy

2015

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(95)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(56)
Humans
(27)
Female
(15)
Social Sciences
(15)
Male
(14)
Animals
(12)
Biological And Medical Sciences
(12)
Physical Sciences
(10)
Chemistry
(8)
Food Science & Technology
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
General & Internal Medicine
(8)
Adult
(7)
Chemistry, Applied
(7)
Education & Educational Research
(7)
Medicine
(7)
Medicine & Public Health
(7)
Mice
(7)
Middle Aged
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Lifelong aerobic exercise protects against inflammaging and cancer

A Five-Ingredient Nutritional Supplement and Home-Based Resistance Exercise Improve Lean Mass and Strength in Free-Living Elderly

Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework

Taking modern psychiatry into the metaverse: Integrating augmented, virtual, and mixed reality technologies into psychiatric care

Correction: Lifelong aerobic exercise protects against inflammaging and cancer

Immersive Virtual Reality for Surgical Training: A Systematic Review

Immersive Virtual Reality for Patient-Specific Preoperative Planning: A Systematic Review

Assessment of 30 Years of Randomized Controlled Trials in The American Journal of Sports Medicine: 1990-2020

A Systematic Review of using Virtual and Augmented Reality for the Diagnosis and Treatment of Psychotic Disorders

Trauma 101: a virtual case-based trauma conference as an adjunct to medical education

Bile Duct Papillary Adenoma Degenerating Into Cholangiocarcinoma: 197

Validity and Reliability of a Rosacea Self-Assessment Tool

Rosacea Patient Perspectives on Homeopathic and Over-the-counter Therapies

Abstract 2745: INK128, a TORC1/2 kinase inhibitor, enhances the efficacy of cytotoxic therapies in endometrial tumor models

Abstract 3753: Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer

Abstract A171: A potent and selective PI3K inhibitor, INK1117, targets human cancers harboring oncogenic PIK3CA mutations

Abstract A172: INK128, an orally active TORC1/2 kinase inhibitor, displays enhanced efficacy when combined with cytotoxic agents

Abstract 4486: INK128, a novel TORC1/2 inhibitor with potent oral antitumor activity in preclinical models of renal cancer

Abstract 4501: INK1117: A potent and orally efficacious PI3Kα-selective inhibitor for the treatment of cancer

Abstract 1668: Pharmacodynamic biomarker development for INK128, a potent and selective inhibitor of TORC1/2 for the treatment of cancer

Abstract 4488: INK128: An orally active TORC1/2 kinase inhibitor demonstrates potent antitumor activity in preclinical models of renal cell carcinoma

Abstract 4496: INK128, an orally active TORC1/2 kinase inhibitor, shows broad antitumor activity and enhances efficacy of cytotoxic as well as targeted agents

Abstract B148: INK128 is a potent and selective TORC1/2 inhibitor with broad oral antitumor activity

Chapter 2 - Proposed curriculum for an interventional psychiatry fellowship program

Book Review

Suchergebnisse filtern